共 23 条
- [1] Re-assessment of the primary efficacy outcomes of cefepime/enmetazobactam versus piperacillin/tazobactam in adult patients with complicated urinary tract infections or acute pyelonephritis using updated EUCAST piperacillin/tazobactam susceptibility breakpoints JAC-ANTIMICROBIAL RESISTANCE, 2024, 6
- [2] Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis A Randomized Clinical Trial JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (13): : 1304 - 1314
- [3] Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysis OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (05):
- [4] Efficacy and safety of piperacillin-tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum β-lactamase-producing Enterobacteriaceae FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
- [7] Efficacy and safety of quinolones for the treatment of uncomplicated urinary tract infections in women: a network meta-analysis International Urogynecology Journal, 2021, 32 : 3 - 15